TIMOTHY BULLOCK: Open Payments
NPI 1710367248 · MONROEVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,565 in 77 payments from 11 companies in 2025. Trend: 2023 $226 · 2024 $1,195 · 2025 $1,565
Food & beverage: $1,565
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $519 |
| Alkermes, Inc. | 10 | $195 |
| Janssen Pharmaceuticals, Inc | 4 | $162 |
| Lundbeck LLC | 8 | $144 |
| Teva Pharmaceuticals USA, Inc. | 9 | $142 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $129 |
| Otsuka America Pharmaceutical, Inc. | 4 | $89 |
| Neurocrine BioSciences, Inc. | 4 | $80 |
| Collegium Pharmaceutical, Inc. | 3 | $55 |
| Axsome Therapeutics, Inc. | 2 | $30 |
Products named: VRAYLAR, REXULTI, SPRAVATO, LYBALVI, CAPLYTA, UZEDY, INGREZZA, AUSTEDO XR.
Industry payments across PA — which companies pay providers there.
